? for Wilson6

[takniteasy]

I was reading some past threads trying to get more info on oxandrolone and came across one of your posts that has gotten my curiosity up. Back in Nov. 2001 in your post you stated that ox is lipolytic by itself and is known to be a fat-burning steroid, particularly abdominal fat. Could you point me to the literature that supports this? Or better yet, explain the science in layman's terms? Pretty please?

P.S. I think the original thread was on anavar dosages

 

[VooDoo Lady]

Back in Nov. 2001 in your post you stated that ox is lipolytic by itself and is known to be a fat-burning steroid, particularly abdominal fat.

AHHHH-HA!!

And to think I was FLAMED into an oblivion when I referred to anavar as a Cutting Drug :

 

[takniteasy]

I believe it helps to some degree with a cutting cycle. We shall see as I am using it as my first cycle while cutting. My research showed that ox is good for helping to preserve muscle mass while cutting. I am just constantly doing research on it and when I saw that post, I geuss I was wanting some clarification and to use the info behind my reasoning for using ox. I surely hope I dont get flamed for it

BTW, VDL you look great! Did you use ox during a cutting cycle because you are one shredded woman!

 

[VooDoo Lady]

BTW, VDL you look great! Did you use ox during a cutting cycle because you are one shredded woman!

Indeed I did...and thanks But I ain't nutin' really...on my way - but not yet

 

[luvs2workout]

Indeed I did...and thanks But I ain't nutin' really...on my way - but not yet

What kind of OX did you use again VDL? Wasnt it **???? LOL!!

 

[Temple]

Spats - I don't think she said it was W6. Just someone flamed her.

 

[wilson6]

Author
Lovejoy JC; Bray GA; Greeson CS; Klemperer M; Morris J; Partington C; Tulley R
Institution Pennington Biomedical Research Center, Baton Rouge, Louisiana 70808-4124, USA.

Title
Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men.

Appears In
INTERNATIONAL JOURNAL OF OBESITY AND RELATED METABOLIC DISORDERS. vol. 19, no. 9 (1995 Sep): 614-24.

Abstract
OBJECTIVE: To compare the effects of testosterone enanthate (TE), anabolic steroid (AS) or placebo (PL) on regional fat distribution and health risk factors in obese middle-aged men undergoing weight loss by dietary means. DESIGN: Randomized, double-blind, placebo-controlled clinical trial, carried out for 9 months with primary assessments at 3 month intervals. Due to adverse blood lipid changes, the AS group was switched from oral oxandrolone (ASOX) to parenteral nandrolone decaoate (ASND) after the 3 month assessment point. SUBJECTS: Thirty healthy, obese men, aged 40-60 years, with serum testosterone (T) levels in the low-normal range (2-5 ng/mL). MAIN OUTCOME MEASURES: Abdominal fat distribution and thigh muscle volume by CT scan, body composition by dual energy X-ray absorptiometry (DEXA), insulin sensitivity by the Minimal Model method, blood lipids, blood chemistry, blood pressure, thyroid hormones and urological parameters. RESULTS: After 3 months, there was a significantly greater decrease in subcutaneous (SQ) abdominal fat in the ASOX group compared to the TE and PL groups although body weight changes did not differ by treatment group. There was also a tendency for the ASOX group to exhibit greater losses in visceral fat, and the absolute level of visceral fat in this group was significantly lower at 3 months than in the TE and PL groups. There were significant main effects of treatment at 3 months on serum T and free T (increased in the TE group and decreased in the ASOX group) and on thyroid hormone parameters (T4 and T3 resin uptake significantly decreased in the ASOX group compared with the other two groups). There was a significant decrease in HDL-C, and increase in LDL-C in the ASOX group, which led to their being switched to the parenteral nandrolone decanoate (ASND) after 3 months. ASND had opposite effects on visceral fat from ASOX, producing a significant increase from 3 to 9 months while continuing to decrease SQ abdominal fat. ASND treatment also decreased thigh muscle area, while ASOX treatment increased high muscle. ASND reversed the effects of ASOX on lipoproteins and thyroid hormones. The previously reported effect of T to decrease visceral fat was not observed, in fact, visceral fat in the TE group increased slightly from 3 to 9 months, although SQ fat continued to decrease. Neither TE nor AS treatment resulted in any change in urologic parameters. CONCLUSIONS: Oral oxandrolone decreased SQ abdominal fat more than TE or weight loss alone and also tended to produce favorable changes in visceral fat. TE and ASND injections given every 2 weeks had similar effects to weight loss alone on regional body fat. Most of the beneficial effects observed on metabolic and cardiovascular risk factors were due to weight loss per se. These results suggest that SQ and visceral abdominal fat can be independently modulated by androgens and that at least some anabolic steroids are capable of influencing abdominal fat.

 

[VooDoo Lady]

VDL, I've been searching for this post where W6 "flamed you into oblivion." Which thread is it on...I can't seem to find anything like that. Is it the one where you asked if anavar was a bulking drug? Where you were trying to add 10 pounds?

Spats...I was using exaggeration to create a humorous effect. I suppose I missed the mark on that one

I DID get a wee bit of grief for it...not quite "flamed into an oblivion."

 

[takniteasy]

Thanks!

Thank you, W6! I sure am glad I remember most of my anatomy and physiology studies I wonder when someone will do a study of the effects of ox on women?

 

[dieslgrl]

I have heard in the past that ox can reduce visceral fat... but I just wanted to say thanks for posting the study...

dg